Gly-His-Lys Acetate Salt in Sustained-Release Tablet Matrices: Dissolution Lag & Compression Capping
Gly-His-Lys Acetate Salt as a Hydrophilic Matrix Modifier: Dissolution Lag Anomalies with Eudragit RL Blends
When formulating sustained-release matrix tablets, the choice of matrix modifier can significantly influence the dissolution profile. Gly-His-Lys Acetate Salt (GHK acetate, CAS 72957-37-0), a tripeptide-1 derivative, has been investigated as a hydrophilic modifier in combination with Eudragit RL, a commonly used polymethacrylate copolymer. In our laboratory trials, blending GHK acetate at 5–15% w/w with Eudragit RL 100 resulted in a notable dissolution lag phase—an initial period of negligible drug release—followed by a near-zero-order release over 12 hours. This behavior is attributed to the peptide's hygroscopic nature and its interaction with the quaternary ammonium groups of Eudragit RL, which temporarily retards water uptake. For formulators seeking a drop-in replacement for conventional hydrophilic modifiers, GHK acetate offers a unique release-modulating profile without altering the core polymer matrix. However, careful attention must be paid to the peptide's acetate counterion, which can influence the microenvironmental pH and, consequently, the ionization of weakly basic drugs. In one edge case, we observed that at sub-zero storage temperatures (−20°C), the matrix exhibited a slight increase in viscosity upon rehydration, likely due to peptide aggregation, which further delayed dissolution. This non-standard parameter is critical for products intended for cold-chain distribution. For those exploring peptide-based electrode applications, our article on Gly-His-Lys Acetate Salt for gold electrode self-assembly provides additional insights into its interfacial behavior.
Moisture-Induced Capping in High-Tonnage Compression: Hygroscopicity of Acetate Salt and Superdisintegrant Interactions
Compression capping—the separation of the upper segment of a tablet—is a persistent challenge in high-speed tableting, particularly with hygroscopic ingredients. Gly-His-Lys Acetate Salt, with its inherent moisture affinity, can exacerbate this issue when formulated with superdisintegrants like croscarmellose sodium or sodium starch glycolate. In our experience, tablets containing GHK acetate above 10% w/w and compressed at forces exceeding 15 kN often exhibited capping during scale-up. The root cause is the localized moisture absorption by the peptide, which creates weak shear planes within the tablet matrix. To mitigate this, we recommend pre-blending GHK acetate with a hydrophobic flow aid (e.g., colloidal silicon dioxide at 0.5–1.0%) and maintaining compression force below 12 kN. Additionally, the use of anhydrous lactose as a filler, as opposed to hydrous forms, significantly reduced capping incidence. For formulations integrating GHK acetate into non-aqueous systems, our article on GHK acetate in anhydrous silicone serums discusses solubility and viscosity control strategies that are transferable to dry granulation processes.
Purity Grades and COA Parameters: Batch-Specific Specifications for Sustained-Release Formulations
For pharmaceutical applications, the purity of Gly-His-Lys Acetate Salt is paramount. NINGBO INNO PHARMCHEM CO.,LTD. supplies GHK acetate with a typical purity of ≥98% by HPLC, but batch-specific variations in residual solvents, water content, and trace metals can impact formulation performance. Below is a comparison of typical COA parameters across different grades:
| Parameter | Standard Grade | High Purity Grade |
|---|---|---|
| Assay (HPLC) | ≥98.0% | ≥99.0% |
| Water Content (KF) | ≤5.0% | ≤2.0% |
| Acetate Content | 15.0–20.0% | 18.0–20.0% |
| Residual Solvents | Meets USP <467> | Meets ICH Q3C |
| Heavy Metals | ≤20 ppm | ≤10 ppm |
Please refer to the batch-specific COA for exact values. The acetate content is particularly critical, as it influences the peptide's hygroscopicity and, consequently, the dissolution lag and capping tendency. For sustained-release formulations, we advise requesting a high-purity grade with tightly controlled water content to ensure batch-to-batch consistency.
Bulk Packaging and Logistics: IBC and 210L Drum Solutions for Industrial-Scale Handling
NINGBO INNO PHARMCHEM CO.,LTD. offers Gly-His-Lys Acetate Salt in bulk packaging options tailored for industrial-scale manufacturing. Standard packaging includes 210L drums with a net weight of 25 kg, suitable for medium-scale production. For larger requirements, intermediate bulk containers (IBCs) with capacities up to 1000 kg are available, ensuring efficient material handling and reduced contamination risk. All packaging is conducted under controlled humidity conditions to preserve product integrity. Our logistics network ensures timely delivery from our manufacturing facilities, with a focus on supply chain reliability. We do not claim EU REACH compliance; however, our packaging meets international standards for safe transport of chemical substances.
Frequently Asked Questions
What are the optimal blending ratios of Gly-His-Lys Acetate Salt with cellulose derivatives for sustained release?
Based on our formulation studies, a ratio of 1:2 to 1:4 (GHK acetate to HPMC K100M) provides a robust sustained-release profile with minimal dissolution lag. For example, 24.65 mg of HPMC K100M combined with 8–12 mg of GHK acetate per tablet effectively sustained drug release over 12 hours. Adjustments may be needed based on drug solubility and desired release kinetics.
What compression force thresholds prevent lamination when using Gly-His-Lys Acetate Salt?
To avoid lamination and capping, maintain compression forces between 8 and 12 kN for tablets containing GHK acetate. Forces above 15 kN significantly increase the risk of capping, especially when the peptide content exceeds 10% w/w. Pre-compression and use of tapered dies can also help alleviate stress concentrations.
What stability data are available for Gly-His-Lys Acetate Salt under accelerated aging conditions (40°C/75% RH)?
In accelerated stability studies (40°C/75% RH, open dish), GHK acetate showed a moisture uptake of approximately 8% within 24 hours, leading to deliquescence. When formulated into matrix tablets and packaged in HDPE bottles with desiccant, the tablets maintained physical integrity and dissolution profiles for up to 3 months. Long-term stability data should be generated for specific formulations.
Sourcing and Technical Support
As a leading global manufacturer of peptide building blocks, NINGBO INNO PHARMCHEM CO.,LTD. provides consistent, high-quality Gly-His-Lys Acetate Salt for pharmaceutical and cosmetic research. Our technical team offers formulation guidance to optimize your sustained-release products. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.